Skip to content

Web-based Patient Education Program to Manage Side Effects of Allogeneic Stem Cell Transplant

Developing and Assessing the Feasibility of Implementing a Video Web-based Patient Education Application

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02812082
Enrollment
0
Registered
2016-06-23
Start date
2016-06-30
Completion date
Unknown
Last updated
2016-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Allo-SCT Survivor, Allo-SCT Patients

Keywords

Web-based, patient education application, 16-769

Brief summary

The purpose of this study is to develop an interactive web-based patient education program to help educate patients about the increased risk of MS and its cardiac risk factors following allo-SCT and to inform and motivate patients how to make lifestyle changes. This program will be used in addition to counseling at participants clinic visits. The investigators are not changing the recommendations for prevention and management of these conditions, but rather are trying to improve the way they provide this education to patients.

Interventions

BEHAVIORALquestionnaire

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The option to participate will be offered to male and female allo-SCT patients at MSK ≥ 21 years of age who are greater than 90 days post-transplant and followed in or referred to the adult allo-SCT survivorship clinic at MSK * The option to participate will be offered to male and female allo-SCT patients at MSK ≥ 21 years of age who are greater than 90 days post-transplant and disease free, but have not yet been referred to the survivorship clinic * Able to understand written and oral English

Exclusion criteria

* Patients less than 90 days post-transplant * Patients without internet access * Adult post-transplant patients who have relapsed prior to study recruitment

Design outcomes

Primary

MeasureTime frameDescription
Percentage of patients that use the application1 yearA successful trial will be when ≥ 50% of enrolled patients use the application.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026